Tumors require a blood supply for growth and hematogenous dissemination. Mu
ch attention has been focused on the role of angiogenesis-the recruitment o
f new vessels into a tumor from pre-existing vessels. However, angiogenesis
may not be the only mechanism by which tumors acquire a microcirculation.
Highly aggressive and metastatic melanoma cells are capable of forming high
ly patterned vascular channels ill vitro that are composed of a basement me
mbrane that stains positive with the periodic acid-Schiff (PAS) reagent in
the absence of endothelial cells and fibroblasts. These channels formed in
vitro are identical morphologically to PAS-positive channels in histologica
l preparations from highly aggressive primary uveal melanomas, in the verti
cal growth phase of cutaneous melanomas, and in metastatic uveal and cutane
ous melanoma. The generation of microvascular channels by genetically dereg
ulated, aggressive tumor cells was termed "vasculogenic mimicry" to emphasi
ze their de novo generation without participation by endothelial cells and
independent of angiogenesis. Techniques designed to identify the tumor micr
ocirculation by the staining of endothelial cells may not be applicable to
tumors that express vasculogenic mimicry. Although it is not known if thera
peutic strategies targeting endothelial cells will be effective in tumors w
hose blood supply is formed by tumor cells in the absence of angiogenesis,
the biomechanical and molecular events that regulate vasculogenic mimicry p
rovide opportunities for the development of novel forms of tumor-targeted t
reatments. The unique patterning characteristic of vasculogenic mimicry pro
vides an opportunity to design noninvasive imaging techniques to detect hig
hly aggressive neoplasms and their metastases.